POSTER SESSION I Monday, February 13, 2006   —  9:30 AM - 12:00 Noon Exhibit Level LIVER & PANCREAS PATHOLOGY 169 Clinicopathologic Correlates of C4d Staining in Pancreas Allografts (1240) A Arslan, J Lim, B Mohammed, R Mann, C Swannick, D Laskow, B Fyfe-Kirschner - UMDNJ - Robert Wood Johnson Medical School; New Brunswick, NJ 170 Multifocal Neoplastic Precursor Lesions Associated With Lobular Atrophy Of The Pancreas In Patients Having A Strong Family History Of Pancreatic Cancer (1249) KA Brune, T Abe, MI Canto, L O'Malley, AP Klein, A Maitra, NV Adsay, E Fishman, JL Cameron, CJ Yeo, SE Kern, MG Goggins, RH Hruban - Johns Hopkins, Baltimore, MD; Karmanos Cancer Center, Detroit, MI 171 Expression Of Nuclear Receptor Co-Activator PRIP (Peroxisome Proliferator-Activated Receptor Interacting Protein) In Human Hepatocellular Carcinomas. (1254) W Cao, P Kashireddy, MS Rao - Feinberg School of Medicine, Northwestern University, Chicago, IL 172 Expression of Claudin-1, Claudin-7, and ZO-1 in Hepatocellular Carcinoma (1257) W Chopp, JD Berlin, R Chari, F Revetta, MK Washington - Vanderbilt University Medical Center, Nashville, TN 173 Identification of Polysomy and Homozygous 9p21 Loss in PSC-Associated and Sporadic Cholangiocarcinoma with Fluorescence in Situ Hybridization (1260) RD DeHaan, BR Kipp, TC Smyrk, SC Abraham, KC Halling - Mayo Clinic, Rochester, MN 174 Anaphase Bridge Analysis as a Biomarker of Hepatitis C Virus (HCV) Hepatic Tumorigenesis (1262) E Downs-Kelly, MP Bronner, B Shadrach, E Swain, RR Tubbs, J O'Sullivan, LM Yerian - Cleveland Clinic Foundation, Cleveland, OH; St Vincent's University Hospital, Dublin, Ireland 175 Immunohistochemical Analysis Of Stromal Cell-Derived Factor-1 (SDF-1) In Human Liver Neoplasms (1264) EM Gomez, X XU, W Li - University of Texas Medical Center, MDA, Houston, TX 176 Galectin-1 As A Pancreatic Cancer Biomarker: Proteomics To Tissue Microarray Validation (1279) Z Lane, R Chen, TA Brentnall, LM Yerian, E Walker, MP Bronner - Cleveland Clinic Foundation, Cleveland, OH; University of Washington, Seattle, WA 177 Pancreatic Mucinous Neoplasms: Analysis of Apomucin and Tumor Suppressor Gene Expression by Tissue Microarray (1292) RK Pai, KC Jensen, EG Fischer, GE Kim, CS Kong - Stanford University, Stanford, CA; University of New Mexico, Albuquerque, NM; University of California, San Francisco, San Francisco, CA 178 The Role of Movat Pentichrome Stain in the Diagnosis of Lymphoplasmocytic Sclerosing Pancreatitis (1294) B Papouchado, Z Lane, MP Bronner - Cleveland Clinic Foundation, Cleveland, OH 179 Hepatocellular Carcinoma in Explanted Livers - Clinicopathological Features of 101 Patients and Development of a Tumor Recurrence Pathological Score (1295) JR Parfitt, M Aighamdi, P Marotta, D Quan, C McLean, B Garcia, W Wall, DK Driman - London Health Sciences Centre (LHSC) / University of Western Ontario (UWO), LHSC /UWO, London, ON, Canada 180 Pseudo-Ground Glass Changes In Liver Biopsies (1310) J Wisell, M Haas, J Boitnott, R Anders, J Hart, J Lewis, SC Abraham, M Torbenson - Johns Hopkins, Baltimore, MD; University of Chicago, Chicago, IL; Mayo Clinic, Rochester, MN 181 Centrizonal Ductular Reaction In Subacute And Chronic Liver Disease (1313) A Yabes, LD Ferrell - Univ of California, San Francisco, CA 182 Panin In Heterotopic Pancreas: Evidence For The Progression Model (1316) L Zhang, SO Sanderson, TC Smyrk - Mayo Clinic, Rochester, MN